Successful use of activated recombinant factor VII to control bleeding abnormalities in a patient with a left ventricular assist device

Journal of Thoracic and Cardiovascular Surgery

Volumn 123, Issue 2, 2002, Pages 384-385

  Zietkiewicz, Mirosław ^a   Garlicki, Mirosław ^a   Domagała, Jerzy ^a   Wierzbicki, Karol ^a   Drwiła, Rafał ^a   Pfitzner, Roman ^a   Dziatkowiak, Antoni ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADULT; ARTICLE; ASSISTED CIRCULATION; BLEEDING DISORDER; CASE REPORT; DRUG EFFECT; HEART LEFT VENTRICLE FUNCTION; HUMAN; IMPLANTATION; KIDNEY FUNCTION; LIVER FUNCTION; MALE; PRIORITY JOURNAL; REOPERATION; SIDE EFFECT; THROMBOSIS;

EID: 0036162022     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2002.119328     Document Type: Article

References (5)

1. Preventing, minimizing, and managing postoperative bleeding
2. Clinical experience with recombinant factor VIIa in patients with thrombocytopenia
3. Successful use of recombinant factor VIIa in a patient with severe hemophilia A during synovectomy
4. Recombinant activated factor VII as a universal haemostatic agent
5. Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery